Saturday, August 08, 2020 3:25:49 PM
Great DD!
Patents Assigned to Regen BioPharma, Inc
Modulation of NR2F6 and methods and uses thereof
Patent number: 9091696
Abstract: The application provides methods of modulating NR2F6 in a cell or animal in need thereof by administering an effective amount of a NR2F6 modulator.
Type: Grant
Filed: October 15, 2012
Date of Patent: July 28, 2015
Assignee: Regen Biopharma, Inc.
Inventors: Christine Victoria Ichim, Richard Alexander Wells
So the grant on that patent I’m assuming is what has made this stock move recently?
Patents Assigned to Regen BioPharma, Inc
Modulation of NR2F6 and methods and uses thereof
Patent number: 9091696
Abstract: The application provides methods of modulating NR2F6 in a cell or animal in need thereof by administering an effective amount of a NR2F6 modulator.
Type: Grant
Filed: October 15, 2012
Date of Patent: July 28, 2015
Assignee: Regen Biopharma, Inc.
Inventors: Christine Victoria Ichim, Richard Alexander Wells
So the grant on that patent I’m assuming is what has made this stock move recently?
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
